These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29431732)

  • 1. STAT3/p53 pathway activation disrupts IFN-β-induced dormancy in tumor-repopulating cells.
    Liu Y; Lv J; Liu J; Liang X; Jin X; Xie J; Zhang L; Chen D; Fiskesund R; Tang K; Ma J; Zhang H; Dong W; Mo S; Zhang T; Cheng F; Zhou Y; Jia Q; Zhu B; Kong Y; Guo J; Zhang H; Hu ZW; Cao X; Qin FX; Huang B
    J Clin Invest; 2018 Mar; 128(3):1057-1073. PubMed ID: 29431732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
    Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
    Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediating the death of dormant tumor cells.
    Liu Y; Lv J; Huang B
    Mol Cell Oncol; 2018; 5(4):e1458013. PubMed ID: 30250912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
    Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy.
    Jia Q; Yang F; Huang W; Zhang Y; Bao B; Li K; Wei F; Zhang C; Jia H
    Theranostics; 2019; 9(2):424-435. PubMed ID: 30809284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner.
    Li F; Zhao Z; Zhang Z; Zhang Y; Guan W
    BMC Cancer; 2021 Oct; 21(1):1112. PubMed ID: 34657603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR.
    Litzenburger UM; Opitz CA; Sahm F; Rauschenbach KJ; Trump S; Winter M; Ott M; Ochs K; Lutz C; Liu X; Anastasov N; Lehmann I; Höfer T; von Deimling A; Wick W; Platten M
    Oncotarget; 2014 Feb; 5(4):1038-51. PubMed ID: 24657910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
    Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
    J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway.
    Lee SM; Park HY; Suh YS; Yoon EH; Kim J; Jang WH; Lee WS; Park SG; Choi IW; Choi I; Kang SW; Yun H; Teshima T; Kwon B; Seo SK
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5881-E5890. PubMed ID: 28673995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
    Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
    Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
    Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
    Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.
    Mezrich JD; Fechner JH; Zhang X; Johnson BP; Burlingham WJ; Bradfield CA
    J Immunol; 2010 Sep; 185(6):3190-8. PubMed ID: 20720200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
    Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
    Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
    Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
    Front Immunol; 2022; 13():832263. PubMed ID: 35371054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling.
    Huang T; Song J; Gao J; Cheng J; Xie H; Zhang L; Wang YH; Gao Z; Wang Y; Wang X; He J; Liu S; Yu Q; Zhang S; Xiong F; Zhou Q; Wang CY
    Nat Commun; 2022 Jun; 13(1):3489. PubMed ID: 35715443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin Stiffness Mediates Dormancy of Tumor-Repopulating Cells via a Cdc42-Driven Tet2 Epigenetic Program.
    Liu Y; Lv J; Liang X; Yin X; Zhang L; Chen D; Jin X; Fiskesund R; Tang K; Ma J; Zhang H; Dong W; Mo S; Zhang T; Cheng F; Zhou Y; Xie J; Wang N; Huang B
    Cancer Res; 2018 Jul; 78(14):3926-3937. PubMed ID: 29764867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of indoleamine 2,3-dioxygenase in ischemia-reperfusion injury of renal tubular epithelial cells.
    Eleftheriadis T; Pissas G; Golfinopoulos S; Liakopoulos V; Stefanidis I
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33899121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
    Lan Q; Peyvandi S; Duffey N; Huang YT; Barras D; Held W; Richard F; Delorenzi M; Sotiriou C; Desmedt C; Lorusso G; Rüegg C
    Oncogene; 2019 Apr; 38(15):2814-2829. PubMed ID: 30546090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism.
    Nguyen NT; Kimura A; Nakahama T; Chinen I; Masuda K; Nohara K; Fujii-Kuriyama Y; Kishimoto T
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19961-6. PubMed ID: 21041655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.